scispace - formally typeset
P

Paul J. van Diest

Researcher at Utrecht University

Publications -  514
Citations -  22750

Paul J. van Diest is an academic researcher from Utrecht University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 70, co-authored 459 publications receiving 18892 citations. Previous affiliations of Paul J. van Diest include University Medical Center Utrecht & VU University Medical Center.

Papers
More filters
Journal ArticleDOI

HER2 testing recommendations in the UK: dual- or single-colour in-situ hybridisation?

TL;DR: The authors state quite firmly that they no longer recommend the use of ISH methods, and advice is given on relevant methodological and interpretation questions such as the need for centralisation, trained staff, quality control and the handling of referral tissue samples.
Journal ArticleDOI

The CONFIDENT-P trial: Clinical implementation of artificial intelligence assistance in prostate cancer pathology.

TL;DR: The CONFIDENT-P trial as discussed by the authors is a SPIRIT-AI compliant single-centre, clinical trial, in a fully digital academic pathology laboratory, in which pathologists will assess whole slide images (WSI) of the standard haematoxylin-eosin (HE)-stained sections assisted by the output of a CE-IVD approved prostate cancer detection and grading algorithm.
Journal ArticleDOI

Time Trends in Histopathological Findings in Mammaplasty Specimens in a Dutch Academic Pathology Laboratory

TL;DR: In this article , the yield of routine pathological investigation of mammaplasty specimens over three decades was evaluated in search of time trends, and significant findings were defined as those that may lead to more intensive follow-up or surgical intervention.
Posted ContentDOI

RNA Helicase DDX3 Regulates RAD51 Localization and DNA Damage Repair in Ewing Sarcoma

TL;DR: In this article , it was shown that DDX3 plays a unique role in DNA damage repair (DDR) in Ewing sarcoma (EWS) cells, and that inhibition of the RNA helicase activity increases RNA:DNA hybrid structures, sequestering RAD51 in the cytoplasm, thus increasing sensitivity of EWS to radiation treatment.